Reported 9 days ago
Eli Lilly has initiated a lawsuit against the federal Health Resources and Services Administration (HRSA) for allegedly obstructing its plan to modify drug discount offerings to hospitals under the 340B program, which provides discounts to healthcare providers serving low-income populations. The company aims to pay cash directly to covered entities while ensuring compliance with the 340B ceiling price. HRSA rejected this approach, leading Lilly to take legal action in Washington D.C. This follows a similar lawsuit by Johnson & Johnson against the Health and Human Services Department regarding drug pricing.
Source: YAHOO